Dr. Erik Salgado Lowman, DO

Dr. Lowman practices at Jackson North Medical Center - Nuclear Medicine - HOPD in North Miami Beach, Florida.

Dr. Lowman's NPI, 1770524944, was assigned on June 9, 2006. Dr. Lowman graduated from Dr. Kiran C. Patel College of Osteopathic Medicine in 2003. Dr. Lowman holds Florida license OS9822.

Dr. Lowman's primary practice is Jackson North Medical Center - Nuclear Medicine - HOPD, at 160 Nw 170th Street, North Miami Beach, FL 33169.

Dr. Lowman's primary practice is Jackson North Medical Center - Nuclear Medicine - HOPD in North Miami Beach, Florida. Dr. Lowman is also affiliated with Jackson Memorial Hospital. The medical group on file is VilMed, Inc., Infectious Disease Specialists. Dmand AI also links Dr. Lowman to 3 more hospitals, 1 physician office and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Lowman practices, 7 sites in all. Vendor and product names are available with a free account.

Infectious disease is Dr. Lowman's primary specialty in the NPI Registry, under taxonomy code 207RI0200X. Dr. Lowman is board certified in infectious disease by the American Board of Internal Medicine. Dr. Lowman is licensed in Florida.

CMS data shows 3,119 Medicare services from Dr. Lowman across 5 procedure codes in 2024, for 594 Medicare patients. Medicare paid $200,415 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 594 Medicare patients who saw Dr. Lowman in 2024. The largest group is 65 to 74, with 198 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 81% are also on Medicaid. Their average risk score is 4.70, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Lowman's median patient age at 59, with 49% women.

In 2024, Dr. Lowman wrote 92 Medicare Part D claims for 12 patients. 65% of them were for generic drugs. CMS names the drug for 12 of them, across 1 drug with 11 or more claims each, at $22,092 in total drug cost. In 2021, CMS named 220 claims across 13 drugs.

Dr. Lowman accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 4 papers to Dr. Lowman, published from 2012 to 2023. Dr. Lowman's most frequent co-authors are Bruce L. Gilliam, MD, Sachin Jain, MD and Peter D. Mazonson, MD.

Dmand AI links Dr. Lowman to 3 clinical trials, 2 of them phase 4 studies. Conditions studied include Acquired Immunodeficiency Syndrome, Slow Virus Diseases and HIV Infections. Midland Research Group, Inc. sponsors the most, 2.

CMS Open Payments shows 809 general payments to Dr. Lowman from 42 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 80% of the total. Gilead Sciences, Inc. paid the most, $4,235. It also lists 8 research payments totaling $977 in 2019.

Dr. Lowman graduated from Dr. Kiran C. Patel College of Osteopathic Medicine in 2003. Dr. Lowman is a member of IDSA.

Dr. Lowman is in network with 10 carriers, including Aetna, United Healthcare and Humana. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.